RACHAEL NERGART: Open Payments
NPI 1811407638 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 24 payments from 9 companies in 2025. Trend: 2023 $426 · 2024 $349 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $143 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| Lilly USA, LLC | 3 | $54 |
| PFIZER INC. | 2 | $44 |
| Abbott Laboratories | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: REXULTI, JARDIANCE, Rybelsus, MOUNJARO, Ozempic, Wegovy, NURTEC ODT, FREESTYLE LIBRE 3.
Industry payments across PA — which companies pay providers there.
